white paper

Can Transcranial Photobiomodulation Improve Cognitive Function in TBI Patients?

/in /by

Abstract

Introduction: Transcranial photobiomodulation (tPBM) is a non-invasive neuromodulation technology which has become a promising therapy for treating many brain diseases. Although it has been confirmed in studies targeting neurological diseases including Alzheimer’s and Parkinson’s that tPBM can improve cognitive function, the effectiveness of interventions targeting TBI patients remains to be determined. This systematic review examines the cognitive outcomes of clinical trials concerning tPBM in the treatment of traumatic brain injury (TBI).

Read more on pubmed.ncbi.nlm.nih.gov or download the PDF»

 

white paper

The Effect of Intranasal Plus Transcranial Photobiomodulation on Neuromuscular Control in Individuals with Repetitive Head Acceleration Events

/in /by

Introduction
Approximately 3.8 million sport- and recreation-related concussions occur annually in the United States. The effects of concussion, including persistent long-term issues with concentration and physical skills is a growing concern. Equally concerning are the effects of repetitive head impacts (RHIs), also known as repetitive head acceleration events (RHAEs). RHAE has the same meaning as RHI; however, it is emerging as a preferred term because it inherently indicates that the brain is experiencing translational and/or rotational movement because of external forces regardless of the source (blast or mechanical blow) or location (head or body) of the impact forces. Although RHAE may include concussions or mild traumatic brain injury (mTBI), most do not result in any acute detectable clinical symptoms. However, the cumulative effect of RHAE, like concussion or mTBI, could progress to traumatic encephalopathy syndrome (TES), a clinical disorder associated with chronic traumatic encephalopathy (CTE). An athlete may experience over 100 RHAEs per season. Although the athlete may be asymptomatic, RHAEs result in microstructural and functional changes in the brain similar to that seen in concussion or mTBI, leading to altered motor unit recruitment strategies, increased acute corticomotor inhibition, and other neuromuscular impairments, such as reduced dynamic balance or reaction time, in the long-term.

Read more on vielight.com or download the PDF

white paper

Effects of Low-Level Light Therapy on Resting-State Connectivity Following Moderate Traumatic Brain Injury: Secondary Analyses of a Double-Blinded Placebo-Controlled Study

/in /by

Abstract

Patients with moderate traumatic brain injury who were administered low-level light therapy within 72 hours after injury showed increased resting-state brain connectivity as measured with functional MRI during the acute to subacute recovery phases compared with sham-treated patients.

Read more on pubs.rsna.org or download  the pdf

white paper

Effects of Low-Level Light Therapy on Resting-State Connectivity Following Moderate Traumatic Brain Injury: Secondary Analyses of a Double-blinded Placebo-controlled Study

/in /by

Abstract

Background Low-level light therapy (LLLT) has been shown to modulate recovery in patients with traumatic brain injury (TBI). However, the impact of LLLT on the functional connectivity of the brain when at rest has not been well studied. Purpose To use functional MRI to assess the effect of LLLT on whole-brain resting-state functional connectivity (RSFC) in patients with moderate TBI at acute (within 1 week), subacute (2-3 weeks), and late-subacute (3 months) recovery phases. Materials and Methods This is a secondary analysis of a prospective single-site double-blinded sham-controlled study conducted in patients presenting to the emergency department with moderate TBI from November 2015 to July 2019. Participants were randomized for LLLT and sham treatment. The primary outcome of the study was to assess structural connectivity, and RSFC was collected as the secondary outcome. MRI was used to measure RSFC in 82 brain regions in participants during the three recovery phases. Healthy individuals who did not receive treatment were imaged at a single time point to provide control values. The Pearson correlation coefficient was estimated to assess the connectivity strength for each brain region pair, and estimates of the differences in Fisher z-transformed correlation coefficients (hereafter, z differences) were compared between recovery phases and treatment groups using a linear mixed-effects regression model. These analyses were repeated for all brain region pairs. False discovery rate (FDR)-adjusted P values were computed to account for multiple comparisons. Quantile mixed-effects models were constructed to quantify the association between the Rivermead Postconcussion Symptoms.

Read more on pubmed.ncbi.nlm.nig.gov or download the PDF

white paper

Photobiomodulation combination therapy as a new insight in neurological disorders: a comprehensive systematic review

/in /by

Abstract

Preclinical and clinical studies have indicated that combining photobiomodulation (PBM) therapy with other therapeutic approaches may influence the treatment process in a variety of disorders. The purpose of this systematic review was to determine whether PBM-combined therapy provides additional benefits over monotherapies in neurologic and neuropsychiatric disorders. In addition, the review describes the most commonly used methods and PBM parameters in these conjunctional approaches.

To accomplish this, a systematic search was conducted in Google Scholar, PubMed, and Scopus databases through January 2024. 95 potentially eligible articles on PBM-combined treatment strategies for neurological and neuropsychological disorders were identified, including 29 preclinical studies and 66 clinical trials.

According to the findings, seven major categories of studies were identified based on disease type: neuropsychiatric diseases, neurodegenerative diseases, ischemia, nerve injury, pain, paresis, and neuropathy. These studies looked at the effects of laser therapy in combination with other therapies like pharmacotherapies, physical therapies, exercises, stem cells, and experimental materials on neurological disorders in both animal models and humans. The findings suggested that most combination therapies could produce synergistic effects, leading to better outcomes for treating neurologic and psychiatric disorders and relieving symptoms.

These findings indicate that the combination of PBM may be a useful adjunct to conventional and experimental treatments for a variety of neurological and psychological disorders.

Read more on bmcneurol.biomedcentral.com or download the PDF»

white paper

Traumatic Brain Injury Recovery with Photobiomodulation: Cellular Mechanisms, Clinical Evidence, and Future Potential

/in /by

By Lew Lim |Mdpi.com | February 23, 2024

Traumatic Brain Injury (TBI) remains a significant global health challenge, lacking effective pharmacological treatments. This shortcoming is attributed to TBI’s heterogeneous and complex pathophysiology, which includes axonal damage, mitochondrial dysfunction, oxidative stress, and persistent neuroinflammation. The objective of this study is to analyze transcranial photobiomodulation (PBM), which employs specific red to near-infrared light wavelengths to modulate brain functions, as a promising therapy to address TBI’s complex pathophysiology in a single intervention.

 

 

white paper

Photobiomodulation for Neurodegenerative Diseases

/in /by

Abstract

Neurodegenerative diseases involve the progressive dysfunction and loss of neurons in the central nervous system and thus present a significant challenge due to the absence of effective therapies for halting or reversing their progression. Based on the characteristics of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), which have prolonged incubation periods and protracted courses, exploring non-invasive physical therapy methods is essential for alleviating such diseases and ensuring that patients have an improved quality of life. Photobiomodulation (PBM) uses red and infrared light for therapeutic benefits and functions by stimulating, healing, regenerating, and protecting organizations at risk of injury, degradation, or death. Over the last two decades, PBM has gained widespread recognition as a non-invasive physical therapy method, showing efficacy in pain relief, anti-inflammatory responses, and tissue regeneration. Its application has expanded into the fields of neurology and psychiatry, where extensive research has been conducted. This paper presents a review and evaluation of studies investigating PBM in neurodegenerative diseases, with a specific emphasis on recent applications in AD and PD treatment for both animal and human subjects. Molecular mechanisms related to neuron damage and cognitive impairment are scrutinized, offering valuable insights into PBM’s potential as a non-invasive therapeutic strategy.

Read more on pbmfoundation.org or download the PDF

white paper

Transcranial Photobiomodulation Treatment: Significant Improvements in Four Ex-Football Players with Possible Chronic Traumatic Encephalopathy

/in , /by

January 31, 2023

Abstract:
Chronic traumatic encephalopathy, diagnosed postmortem (hyperphosphorylated tau), is preceded by traumatic encephalopathy syndrome with worsening cognition and behavior/mood disturbances, over years. Transcranial photobiomod- ulation (tPBM) may promote improvements by increasing ATP in compromised/stressed cells and increasing local blood, lymphatic vessel vasodilation.

READ ONLINE»  |  DOWNLOAD PDF»

Transcranial Photobiomodulation Treatment Effects in Former Athletes with Repetitive Head Hits

/in /by

Concussion (i.e., mild traumatic brain injury) and repetitive sub-concussive head hits are recognized by the sports medicine community and society at large as a major
public health concern. Psychiatric and neurocognitive functioning disruption and sleep disturbance are associated with these injuries. Transcranial photobiomodulation (tPBM) has been
proposed as a non-invasive treatment.

Download the PDF provided by the University of Utah »

 

Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders

/in /by

Irradiation in the red/near-infrared spectrum (R/NIR, 630–1000 nm) has been used to treat a wide range of clinical conditions, including disorders of the central nervous system (CNS), with several clinical trials currently underway for stroke and macular degeneration. However, R/NIR irradiation therapy (R/NIR-IT) has not been widely adopted in clinical practice for CNS injury or disease for a number of reasons, which include the following. The mechanism/s of action and implications of penetration have not been thoroughly addressed. The large range of treatment intensities, wavelengths and devices that have been assessed make comparisons difficult, and a consensus paradigm for treatment has not yet emerged. Furthermore, the lack of consistent positive outcomes in randomised controlled trials, perhaps due to sub-optimal treatment regimens, has contributed to scepticism. This review provides a balanced précis of outcomes described in the literature regarding treatment modalities and efficacy of R/NIR-IT for injury and disease in the CNS. We have addressed the important issues of specification of treatment parameters, penetration of R/NIR irradiation to CNS tissues and mechanism/s, and provided the necessary detail to demonstrate the potential of R/NIR-IT for the treatment of retinal degeneration, damage to white matter tracts of the CNS, stroke and Parkinson’s disease.

 

Read more on PubMed »